Breast Cancer Therapeutics
Middle East
Updated
Reviewed by Chandani Patel
Middle East Malaria Vaccines Market Industry Trends and Forecast to 2034: Segmented by (Product, Region, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$87.9 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $10.0 Mn | — | — |
| 2025 (base) | $12.5 Mn | +$2.6 Mn | — |
| 2026 (forecast) | $15.8 Mn | +$3.3 Mn | +26% |
| 2027 (forecast) | $19.9 Mn | +$4.1 Mn | +58.8% |
| 2028 (forecast) | $25.1 Mn | +$5.2 Mn | +100% |
| 2029 (forecast) | $31.6 Mn | +$6.5 Mn | +152% |
| 2030 (forecast) | $39.8 Mn | +$8.2 Mn | +217.6% |
| 2031 (forecast) | $50.2 Mn | +$10.4 Mn | +300.2% |
| 2032 (forecast) | $63.2 Mn | +$13.0 Mn | +404.2% |
| 2033 (forecast) | $79.7 Mn | +$16.4 Mn | +535.3% |
| 2034 (forecast) | $100.4 Mn | +$20.7 Mn | +700.5% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $12.5 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $100.4 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 26.0% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, region and end user (see all) |
| Key players | GSK PLC, Serum Institute of India, Bharat Biotech, Sanaria, BioNTech (see all) |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Malaria vaccines protect young children in high-risk areas against malaria, a leading cause of child deaths in Africa.
Key segments of the malaria Vaccines market include product (RTS,S/AS01, R21/Matrix-M and Candidates) and region (Sub-Saharan Africa, Asia and Latin America).
Rising antimicrobial resistance, outbreaks of new and returning diseases, climate change spreading infections and strong global funding for prevention are driving the malaria Vaccines market.
New vaccines, rapid tests and public-private funding for neglected diseases give the malaria Vaccines market room to grow, especially in Asia, Africa and Latin America.
Low prices in poorer markets, weak returns for new antibiotics, vaccine hesitancy and cold-chain problems hold back the malaria Vaccines market.
The malaria Vaccines market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
In some of the countries we cover here, medicines are approved by SFDA (Saudi Arabia)[1] and EDE (UAE)[2]. How care is paid for in some of these countries: free public care and CHI-regulated insurance (Saudi Arabia)[3] and mandatory health insurance (UAE)[4].
[1] Saudi Food and Drug Authority. Checked 14 Nov 2026.
[2] Emirates Drug Establishment. Checked 14 Nov 2026.
[3] Council of Health Insurance. Checked 14 Nov 2026.
[4] Ministry of Human Resources and Emiratisation. Checked 14 Nov 2026.
Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for malaria Vaccines. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Middle East.
What doctors and scientists are doing in Malaria Vaccines right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
Middle East
Middle East
Middle East
Middle East
Middle East
Middle East
Public Health · Middle East
Public Health · Middle East
OTC & Nutraceuticals · Middle East
Medical Devices · Middle East
Public Health · Global
Public Health · Global